Literature DB >> 8429218

Investigation of human platelet alloantigens and glycoproteins using non-radioactive immunoprecipitation.

J W Smith1, C P Hayward, T E Warkentin, P Horsewood, J G Kelton.   

Abstract

Sensitive techniques to detect platelet antibodies are needed for the investigation of immune thrombocytopenic syndromes such as neonatal alloimmune thrombocytopenia and post-transfusion purpura. Radioimmunoprecipitation has proved useful in the investigation of platelet-antibody interactions; however, the requirement for a radioactive label is a disadvantage. We describe the immunoprecipitation of human platelet proteins labelled with nonradioactive NHSS-biotin and compare the results with proteins labelled with 125I. The efficiency of labelling was evaluated by immunoprecipitation using well-characterized human anti-platelet antisera and murine monoclonal antibodies. The immunoprecipitated proteins were separated by SDS-PAGE, transferred to nitrocellulose and detected using streptavidin-horseradish peroxidase and a chemiluminescent substrate with exposure to X ray film. The biotinylation technique labelled glycoproteins Ia/IIa, Ib/IX, IIb/IIIa, IV, and p175 which carry all of the known platelet alloantigens and isoantigens. It was as sensitive as radiolabelling and had the advantage of labelling GPs Ib beta and IX, which were not labelled using radioiodine. Human sera containing alloantibodies to HPA-1a on GP IIIa, HPA-3a on GP IIb, HPA-5a and HPA-5b on GP Ia, Govb on p175, and the isoantibody Naka on GP IV precipitated the corresponding biotinylated proteins. Biotinylated proteins could be detected using a 30 s exposure compared to 2 days or longer for 125I. Immunoprecipitation of human platelet glycoproteins labeled with NHSS-biotin is a fast and sensitive alternative to conventional radioimmunoprecipitation for the study of human platelet antigens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8429218     DOI: 10.1016/0022-1759(93)90260-e

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Acute thrombocytopenia in patients treated with amiodarone is caused by antibodies specific for platelet membrane glycoproteins.

Authors:  Mervyn A Sahud; Michael Caulfield; Nigel Clarke; Robert Koch; Daniel Bougie; Richard Aster
Journal:  Br J Haematol       Date:  2013-08-19       Impact factor: 6.998

2.  Laboratory investigation of immune thrombocytopenia.

Authors:  M Warner; J G Kelton
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

3.  Peripheral blood mononuclear cells from sheep infected with a variant of bovine leukemia virus synthesize envelope glycoproteins but fail to induce syncytia in culture.

Authors:  E R Johnston; M A Powers; L C Kidd; K Radke
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Recapitulation of posttransfusion purpura by cross-strain platelet immunization in mice.

Authors:  Daniel W Bougie; Jessica Sutton; Richard H Aster
Journal:  Blood Adv       Date:  2020-01-28

5.  Molecular basis of CD36 deficiency. Evidence that a 478C-->T substitution (proline90-->serine) in CD36 cDNA accounts for CD36 deficiency.

Authors:  H Kashiwagi; Y Tomiyama; S Honda; S Kosugi; M Shiraga; N Nagao; S Sekiguchi; Y Kanayama; Y Kurata; Y Matsuzawa
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.